Literature DB >> 11850585

Coexpression of MUC1 with p53 or MUC2 correlates with lymph node metastasis in colorectal carcinomas.

Kee Taek Jang1, Seoung Wan Chae, Jin Hee Sohn, Hye Rim Park, Hyung Sik Shin.   

Abstract

The alteration of the mucin profile have been known to play a role in colorectal carcinogenesis. MUC1 is up-regulated and MUC2 is down-regulated in colorectalcarcinomas. Overexpression of p53 is frequently noted in colorectal carcinomas with deep invasion or lymph node metastasis. However, there have been few reports about the association between MUC1, MUC2, and p53 expression with respect to the metastatic potential. This study was aimed to investigate the relationship of MUC1, MUC2, and protein p53 expressions with clinicopathological factors in colorectal carcinomas. Expressions of MUC1, MUC2, and p53 protein were examined immunohistochemically. Of total 97 cancers, 44 (45%) were MUC1 positive, 39 (40%) were MUC2 positive and 58 (59%) showed a p53 overexpression. Coexpression of MUC1 with p53 and dual expression of MUC1 with MUC2 were associated with a higher frequency of lymph node metastasis (p<0.05). The right colon showed a higher MUC1 positivity and frequent lymph node metastasis than the left colon (p<0.05). These results suggest that the coexpression of MUC 1 with p53 or MUC2 are involved in regional lymph node metastasis in colorectal carcinomas. The high expression of MUC1 in the right colon cancer was revealed to relate with lymph node metastasis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850585      PMCID: PMC3054826          DOI: 10.3346/jkms.2002.17.1.29

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  7 in total

1.  The complex intratumoral heterogeneity of colon cancer highlighted by laser microdissection.

Authors:  David Buob; Harold Fauvel; Marie-Pierre Buisine; Stéphanie Truant; Christophe Mariette; Nicole Porchet; Agnès Wacrenier; Marie-Christine Copin; Emmanuelle Leteurtre
Journal:  Dig Dis Sci       Date:  2011-12-25       Impact factor: 3.199

2.  Differentiation pathways in duodenal and ampullary carcinomas: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinomas.

Authors:  Yesim Gürbüz; Günter Klöppel
Journal:  Virchows Arch       Date:  2004-04-08       Impact factor: 4.064

Review 3.  MUC1 and MUC2 in pancreatic neoplasia.

Authors:  E Levi; D S Klimstra; A Andea; O Basturk; N V Adsay
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

4.  Clinicopathological Significance of Mucin 2 Immuno-histochemical Expression in Colorectal Cancer: A Meta-Analysis.

Authors:  Li Li; Pei-Lin Huang; Xiao-Jin Yu; Xiao-Dong Bu
Journal:  Chin J Cancer Res       Date:  2012-09       Impact factor: 5.087

5.  Differential expression of MUC genes in endometrial and cervical tissues and tumors.

Authors:  Vidya Hebbar; Gautam Damera; Goverdhan P Sachdev
Journal:  BMC Cancer       Date:  2005-09-27       Impact factor: 4.430

Review 6.  MUC1 Predicts Colorectal Cancer Metastasis: A Systematic Review and Meta-Analysis of Case Controlled Studies.

Authors:  Yunhui Zeng; Qiongwen Zhang; Yujie Zhang; Minxun Lu; Yang Liu; Tianying Zheng; Shijian Feng; Meiqin Hao; Huashan Shi
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

7.  Prognostic and clinicopathological value of MUC1 expression in colorectal cancer: A meta-analysis.

Authors:  Chao Li; Tao Liu; Libin Yin; Didi Zuo; Yuyang Lin; Lei Wang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.